C. Hagerling

Oncology · 2018

A researcher in the Science corpus: 1 paper; trusts 5 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom C. Hagerling trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Raulet
  2. Binzhi Qian
  3. J. Massagué

Papers from C. Hagerling's perspective

Ordered by how strongly the researchers C. Hagerling trusts endorse each paper. Same corpus, a different order for every researcher.

  1. CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis (Nature)
  2. Hallmarks of cancer: the next generation. (Cell)
  3. Polarization of Tumor-Associated Neutrophil (TAN) Phenotype by TGF-β: “N1” versus “N2” TAN (Cancer Cell)
  4. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity (Nature)
  5. Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis (Nature)
  6. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. (Trends in immunology)
  7. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. (Cancer Cell)
  8. The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
  9. Neutrophils support lung colonization of metastasis-initiating breast cancer cells (Nature)
  10. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients (Nature)

Their papers